Joong-Won Park

13PUBLICATIONS
29CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targetsDisease surveillancePredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Apr 07, 2026
Second-Line and Subsequent Therapies after Atezolizumab Plus Bevacizumab Treatment in Hepatocellular Carcinoma: A Multicenter Prospective Cohort Study.

Yuri Cho, Jeong-Hoon Lee, Baek-Yeol Ryoo

|Jun 29, 2023
Ruptured Massive Hepatocellular Carcinoma Cured by Transarterial Chemoembolization.

Ji Eun Lee, Joong-Won Park, In Joon Lee

|Jun 29, 2023
A case of successful surgical treatment for peritoneal seeding of hepatocellular carcinoma after radiotherapy and atezolizumab plus bevacizumab combination treatment.

Yuri Cho, Bo Hyun Kim, Tae Hyun Kim

|Jun 29, 2023
Sorafenib combined with radiation therapy for advanced hepatocellular carcinoma with portal and hepatic vein invasion extending to the inferior vena cava: a complete response case according to modified RECIST criteria.

Yuri Cho, Bo Hyun Kim, Tae Hyun Kim

|Jun 29, 2023
Systemic therapy for advanced hepatocellular carcinoma: consideration for selecting second-line treatment.

Bo Hyun Kim, Joong-Won Park

|Jun 19, 2023
Sorafenib for 9,923 Patients with Hepatocellular Carcinoma: An Analysis from National Health Insurance Claim Data in South Korea.

Sojung Han, Do Young Kim, Ho Yeong Lim

Pageof 3

Frequent Collaborators

5 joint publications

Bo Hyun Kim

4 joint publications

Yuri Cho

2 joint publications

Tae Hyun Kim

2 joint publications

Baek-Yeol Ryoo